GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » Earnings per Share (Diluted)

YSB (HKSE:09885) Earnings per Share (Diluted) : HK$0.05 (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is YSB Earnings per Share (Diluted)?

YSB's Earnings per Share (Diluted) for the six months ended in Dec. 2024 was HK$0.02. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.05.

YSB's EPS (Basic) for the six months ended in Dec. 2024 was HK$0.02. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.05.

YSB's EPS without NRI for the six months ended in Dec. 2024 was HK$-0.02. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0.01.


YSB Earnings per Share (Diluted) Historical Data

The historical data trend for YSB's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YSB Earnings per Share (Diluted) Chart

YSB Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Earnings per Share (Diluted)
-1.07 -0.97 -2.65 -9.04 0.05

YSB Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Earnings per Share (Diluted) Get a 7-Day Free Trial -1.53 -25.92 -0.07 0.03 0.02

Competitive Comparison of YSB's Earnings per Share (Diluted)

For the Pharmaceutical Retailers subindustry, YSB's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


YSB's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, YSB's PE Ratio distribution charts can be found below:

* The bar in red indicates where YSB's PE Ratio falls into.


;
;

YSB Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

YSB's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2024 is calculated as

Diluted Earnings Per Share (A: Dec. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(16.102-0)/657.347
=0.02

YSB's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2024 is calculated as

Diluted Earnings Per Share (Q: Dec. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-7.195-0)/666.390
=-0.01

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


YSB  (HKSE:09885) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


YSB Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of YSB's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


YSB Business Description

Traded in Other Exchanges
Address
No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN
YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.
Executives
Zhang Buzhen 2501 Other
Chen Xiaohong 2201 Interest of corporation controlled by you
H Capital V, L.p. 2101 Beneficial owner
H Capital V Gp, Ltd. 2201 Interest of corporation controlled by you
H Capital V Gp, L.p. 2201 Interest of corporation controlled by you
Shleifer Scott 2201 Interest of corporation controlled by you
Internet Fund Holding V. Ltd. 2201 Interest of corporation controlled by you
Tiger Global Management, Llc 2102 Investment manager
Tiger Global Pip Performance Xi, L.p. 2201 Interest of corporation controlled by you
Tiger Global Private Investment Partners Xi, L.p. 2101 Beneficial owner
Coleman Iii Charles 2201 Interest of corporation controlled by you
Miyt Worldwide Limited 2201 Interest of corporation controlled by you
Tmf (cayman) Ltd. 2301 Trustee
Internet Fund V Pte. Ltd. 2306 Nominee for another person
Miyt Holdings Limited 2101 Beneficial owner

YSB Headlines

No Headlines